As of October 31, 2019, the largest concentration of Candida auris cases — 427 of 911 confirmed cases — is in New York4, according to an article on the Infection Control Today website.
“Approximately 3 years into the New York outbreak, these pan-resistant isolates still appear to be rare, but their emergence is concerning,” investigators have said.
C. auris cases in New York are primarily concentrated among hospital patients and nursing home residents in New York City.
The investigators recommended that patients on antifungal treatment for C. auris should be monitored closely for clinical improvement, and follow-up cultures should be obtained.
Grounding Healthcare Spaces in Hospitality Principles
UC Davis Health Selects Rudolph and Sletten for Central Utility Plant Expansion
Cape Cod Healthcare Opens Upper 2 Floors of Edwin Barbey Patient Care Pavilion
Building Sustainable Healthcare for an Aging Population
Froedtert ThedaCare Announces Opening of ThedaCare Medical Center-Oshkosh